SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-068795
Filing Date
2023-12-07
Accepted
2023-12-07 16:05:17
Documents
1
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2755
  Complete submission text file 0000950170-23-068795.txt   4106
Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Higgins Michael J (Reporting) CIK: 0001478521 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38787 | Film No.: 231472378

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Issuer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations